|
|
 |
 |
 |
   |
Zhu Qigao
Director of Biopharmaceutical Department
Science and Technology Commission of Shanghai Municipal |
 |
Li Ge
CEO
PharmaTech |
|
Fan Xue Dong
Asia Center Manager of Global CRO Research
Pfizer |
|
Umesh Dalvi
Head of Global External Manufacturing,
Bristol-Myers Squibb |
Jun Bao, Ph.D., MBA
Director of Corporate Development and Financial Planning
Onyx Pharmaceuticals
|
|
Wenny Du, M.D.,
Asia Pacific Medical Marketing Director
Bayer Schering Pharma |
|
James Cai, M.D
Vice President, R&D and Business Development
AstraZeneca Pharmaceuticals, China |
|
Steve Yang, Ph.D.,
Head of Research, Asia (excluding Japan)
Pfizer Global R&D |
Barbara Yanni, Ph.D
Chief Licensing Officer and Vice President
Merck & Co., In |
|
Liu Xiao Long
Board Chairman
Shanghai Zhangjiang Biotech pharmaceutical Base |
|
Dr.John Gu
Vice Chairman
Shanghai Genecore Biotechnologies |
|
Dr Peter Schu
GlaxoSmithCline |
|
Lei Zhang, MD. PhD (Former FDA Official)
Head of China Office
Biologics Consulting Group, Inc. USA |
|
 |
 |
|
|
